Related Experiment Video
Updated: Jul 29, 2026

Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers
Published on: September 29, 2017
Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases
Miao-Miao Lin1, Na Liu1, Zheng-Hong Qin1
1Department of Pharmacology and Laboratory of Aging and Nervous Diseases and Jiangsu Key Laboratory of Neuropsychiatric Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China.
Abstract:
Both mitochondrial dysfunction and neuroinflammation are implicated in neurodegeneration and neurodegenerative diseases. Accumulating evidence shows multiple links between mitochondrial dysfunction and neuroinflammation. Mitochondrial-derived damage-associated molecular patterns (DAMPs) are recognized by immune receptors of microglia and aggravate neuroinflammation. On the other hand, inflammatory factors released by activated glial cells trigger an intracellular cascade, which regulates mitochondrial metabolism and function. The crosstalk between mitochondrial dysfunction and neuroinflammatory activation is a complex and dynamic process. There is strong evidence that mitochondrial dysfunction precedes neuroinflammation during the progression of diseases. Thus, an in-depth understanding of the specific molecular mechanisms associated with mitochondrial dysfunction and the progression of neuroinflammation in neurodegenerative diseases may contribute to the identification of new targets for the treatment of diseases. In this review, we describe in detail the DAMPs that induce or aggravate neuroinflammation in neurodegenerative diseases including mtDNA, mitochondrial unfolded protein response (mtUPR), mitochondrial reactive oxygen species (mtROS), adenosine triphosphate (ATP), transcription factor A mitochondria (TFAM), cardiolipin, cytochrome c, mitochondrial Ca2+ and iron.
Insights
Mitochondrial dysfunction and neuroinflammation are key in neurodegeneration. Understanding their links, like mitochondrial DAMPs triggering inflammation, offers new therapeutic targets for these diseases.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Mitochondrial dysfunction and neuroinflammation are hallmarks of neurodegenerative diseases.
- Evidence highlights intricate crosstalk between cellular energy production and immune responses in the brain.
- Mitochondrial damage-associated molecular patterns (DAMPs) and glial inflammatory factors mediate this interaction.
Purpose of the Study:
- To review the molecular mechanisms linking mitochondrial dysfunction and neuroinflammation in neurodegeneration.
- To elucidate the role of mitochondrial-derived DAMPs in exacerbating neuroinflammation.
- To identify potential therapeutic targets by understanding this complex interplay.
Main Methods:
- Literature review focusing on molecular mechanisms.
- Analysis of studies detailing the bidirectional communication between mitochondria and glial cells.
- Compilation of evidence on specific mitochondrial components acting as DAMPs.
Main Results:
- Mitochondrial dysfunction often precedes and drives neuroinflammation in disease progression.
- Mitochondrial DAMPs, including mtDNA, mtUPR, mtROS, ATP, TFAM, cardiolipin, cytochrome c, mitochondrial Ca2+, and iron, activate microglial immune responses.
- Neuroinflammation, in turn, modulates mitochondrial metabolism and function via inflammatory mediators.
Conclusions:
- The dynamic crosstalk between mitochondrial dysfunction and neuroinflammation is central to neurodegenerative disease pathogenesis.
- Targeting mitochondrial-derived DAMPs or the inflammatory pathways they activate presents promising therapeutic strategies.
- Further research into these specific molecular links is crucial for developing effective treatments for neurodegenerative conditions.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology

